Deepak Nagra

1.6k total citations
25 papers, 124 citations indexed

About

Deepak Nagra is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Deepak Nagra has authored 25 papers receiving a total of 124 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Deepak Nagra's work include Sarcoidosis and Beryllium Toxicity Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and COVID-19 Clinical Research Studies (3 papers). Deepak Nagra is often cited by papers focused on Sarcoidosis and Beryllium Toxicity Research (4 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and COVID-19 Clinical Research Studies (3 papers). Deepak Nagra collaborates with scholars based in United Kingdom, United States and Canada. Deepak Nagra's co-authors include James Galloway, Maryam Adas, April Buazon, Jennifer Hannah, Sam Norton, Mark Russell, Mark Yates, Katie Bechman, Patrick Gordon and Andrew I Rutherford and has published in prestigious journals such as PLoS ONE, Annals of the Rheumatic Diseases and European Respiratory Journal.

In The Last Decade

Deepak Nagra

19 papers receiving 124 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepak Nagra United Kingdom 6 47 40 34 22 16 25 124
Jubran Alqanatish Saudi Arabia 6 34 0.7× 27 0.7× 31 0.9× 28 1.3× 12 0.8× 22 179
Christos Gogos Greece 6 107 2.3× 25 0.6× 28 0.8× 60 2.7× 13 0.8× 20 248
Claire McGroder United States 6 75 1.6× 82 2.0× 29 0.9× 38 1.7× 22 1.4× 12 218
Constantin Habimana Mugabo Sweden 3 95 2.0× 42 1.1× 15 0.4× 12 0.5× 8 0.5× 7 150
Aránzazu Sancho‐López Spain 6 101 2.1× 71 1.8× 28 0.8× 21 1.0× 16 1.0× 19 167
Fadi Kharouf Canada 5 72 1.5× 30 0.8× 17 0.5× 28 1.3× 6 0.4× 35 142
Artemis Papadaki United Kingdom 4 69 1.5× 65 1.6× 19 0.6× 15 0.7× 17 1.1× 8 175
Milad Gholizadeh Mesgarha Iran 7 52 1.1× 11 0.3× 15 0.4× 42 1.9× 15 0.9× 19 127
Han A. Li United States 7 55 1.2× 30 0.8× 17 0.5× 26 1.2× 29 1.8× 9 120
Oliver Schreiner Germany 7 28 0.6× 19 0.5× 14 0.4× 35 1.6× 7 0.4× 11 135

Countries citing papers authored by Deepak Nagra

Since Specialization
Citations

This map shows the geographic impact of Deepak Nagra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Nagra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Nagra more than expected).

Fields of papers citing papers by Deepak Nagra

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Nagra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Nagra. The network helps show where Deepak Nagra may publish in the future.

Co-authorship network of co-authors of Deepak Nagra

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Nagra. A scholar is included among the top collaborators of Deepak Nagra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Nagra. Deepak Nagra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nagra, Deepak, Chris Wincup, Arti Mahto, et al.. (2025). The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors: a review of the literature. Lara D. Veeken. 64(11). 5641–5646. 2 indexed citations
2.
Nagra, Deepak, Maryam Adas, Mark Russell, et al.. (2025). Association of race and ethnicity with mortality in adults with SLE: a systematic literature review and meta-analysis. Lupus Science & Medicine. 12(1). e001383–e001383.
3.
Nagra, Deepak, Katie Bechman, C.I. Baldwin, et al.. (2024). POS0867 INFLIXIMAB THERAPY FOR MULTISYSTEM SARCOIDOSIS: A SINGLE CENTRE EXPERIENCE. Annals of the Rheumatic Diseases. 83. 854–854.
4.
Nagra, Deepak, Katie Bechman, Mark Russell, et al.. (2024). No Waning of Pneumococcal Vaccine Responses over Time in People with Inflammatory Arthritis: Findings from a Single Centre Cohort. Vaccines. 12(1). 69–69. 1 indexed citations
5.
Nagra, Deepak, Katie Bechman, Mark Russell, et al.. (2024). Pneumococcal vaccine uptake in patients with inflammatory arthritis: a single centre cohort study. Lara D. Veeken. 64(5). 2479–2486. 1 indexed citations
6.
Nagra, Deepak, et al.. (2023). OA14 The role of anifrolumab in treating life threatening systemic lupus erythematosus with severe mucocutaneous involvement. Rheumatology Advances in Practice. 7(Supplement_2). 1 indexed citations
7.
Yates, Mark, Katie Bechman, Maryam Adas, et al.. (2023). Online Patient-Reported Outcome Measure Engagement Is Dependent on Demographics and Locality: Findings From an Observational Cohort. The Journal of Rheumatology. 50(9). 1178–1184. 4 indexed citations
8.
Nagra, Deepak, et al.. (2023). OA12 Grimey granulomas of sarcoidosis. Rheumatology Advances in Practice. 7(Supplement_2).
9.
Nagra, Deepak, Katie Bechman, Maryam Adas, et al.. (2023). A Systematic Review and Meta-Analysis of Anti-Rheumatic Drugs and Pneumococcal Vaccine Immunogenicity in Inflammatory Arthritis. Vaccines. 11(11). 1680–1680. 4 indexed citations
10.
Bechman, Katie, Maryam Adas, Deepak Nagra, et al.. (2023). Incidence of Uveitis in Patients With Axial Spondylarthritis Treated With Biologics or Targeted Synthetics: A Systematic Review and Network Meta‐Analysis. Arthritis & Rheumatology. 76(5). 704–714. 4 indexed citations
11.
Bechman, Katie, Mark Yates, Deepak Nagra, et al.. (2022). Inpatient COVID-19 mortality has reduced over time: Results from an observational cohort. PLoS ONE. 17(1). e0261142–e0261142. 15 indexed citations
12.
Hannah, Jennifer, April Buazon, Maryam Adas, et al.. (2022). A Systematic Review and Metaanalysis of Predictors of Mortality in Idiopathic Inflammatory Myopathy–Associated Interstitial Lung Disease. The Journal of Rheumatology. 50(3). jrheum.220383–jrheum.220383. 9 indexed citations
13.
Nagra, Deepak, Mark Russell, Edward Alveyn, et al.. (2022). Diagnosing Camurati–Engelmann disease—the age of whole-exome sequencing. Lara D. Veeken. 62(7). e221–e222. 1 indexed citations
14.
Russell, Mark, Deepak Nagra, Benjamin D Clarke, et al.. (2022). Hospitalizations for Acute Gout: Process Mapping the Inpatient Journey and Identifying Predictors of Admission. The Journal of Rheumatology. 49(7). 725–730. 1 indexed citations
15.
Rampes, Sanketh, Ailsa Bosworth, Deepak Nagra, et al.. (2021). Systematic Review and Metaanalysis of the Reproducibility of Patient Self-reported Joint Counts in Rheumatoid Arthritis. The Journal of Rheumatology. 48(12). 1784–1792. 5 indexed citations
16.
Buazon, April, Jennifer Hannah, Maryam Adas, et al.. (2021). IL-6 inhibition in the treatment of COVID-19: A meta-analysis and meta-regression. Journal of Infection. 82(5). 178–185. 35 indexed citations
17.
Bechman, Katie, Mark Yates, Deepak Nagra, et al.. (2021). Inpatient COVID-19 Mortality Has Reduced Over Time: Results from an Observational Cohort. SSRN Electronic Journal. 2 indexed citations
18.
Nagra, Deepak, Mark Russell, Stefania Rosmini, et al.. (2021). A Kawasaki-like illness in an adult with recent SARS-CoV-2 infection. Rheumatology Advances in Practice. 5(2). rkab035–rkab035. 1 indexed citations
19.
Nagra, Deepak, Mark Russell, Mark Yates, et al.. (2020). COVID-19: opacification score is higher in the right lung and right lung involvement is a better predictor of ICU admission. European Respiratory Journal. 56(6). 2002340–2002340. 5 indexed citations
20.
Mahto, Arti, et al.. (2020). EP13 A case of candida albicans septic sacroiliitis complicating severe COVID-19 infection. Rheumatology Advances in Practice. 4(Supplement_1). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jubran Alqanatish Breakdown of academic impact, for papers by Christos Gogos Breakdown of academic impact, for papers by Claire McGroder Breakdown of academic impact, for papers by Constantin Habimana Mugabo Breakdown of academic impact, for papers by Aránzazu Sancho‐López Breakdown of academic impact, for papers by Fadi Kharouf Breakdown of academic impact, for papers by Artemis Papadaki Breakdown of academic impact, for papers by Milad Gholizadeh Mesgarha Breakdown of academic impact, for papers by Han A. Li Breakdown of academic impact, for papers by Oliver Schreiner
Rankless by CCL
2026